These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16846009)

  • 41. Genetic manipulation of human embryonic stem cells.
    Epsztejn-Litman S; Eiges R
    Methods Mol Biol; 2010; 584():387-411. PubMed ID: 19907989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High density cultures of embryonic stem cells.
    Oh SK; Fong WJ; Teo Y; Tan HL; Padmanabhan J; Chin AC; Choo AB
    Biotechnol Bioeng; 2005 Sep; 91(5):523-33. PubMed ID: 16044469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distinct developmental ground states of epiblast stem cell lines determine different pluripotency features.
    Bernemann C; Greber B; Ko K; Sterneckert J; Han DW; Araúzo-Bravo MJ; Schöler HR
    Stem Cells; 2011 Oct; 29(10):1496-503. PubMed ID: 21898681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA damage response and mutagenesis in mouse embryonic stem cells.
    Hong Y; Cervantes RB; Stambrook PJ
    Methods Mol Biol; 2006; 329():313-26. PubMed ID: 16846001
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Derivation, maintenance, and induction of the differentiation in vitro of equine embryonic stem cells.
    Saito S; Sawai K; Minamihashi A; Ugai H; Murata T; Yokoyama KK
    Methods Mol Biol; 2006; 329():59-79. PubMed ID: 16845984
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monkey embryonic stem cell lines expressing green fluorescent protein.
    Takada T; Suzuki Y; Kondo Y; Kadota N; Kobayashi K; Nito S; Kimura H; Torii R
    Cell Transplant; 2002; 11(7):631-5. PubMed ID: 12518890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Homologous feeder cells support undifferentiated growth and pluripotency in monkey embryonic stem cells.
    Li T; Wang S; Xie Y; Lu Y; Zhang X; Wang L; Yang S; Wolf D; Zhou Q; Ji W
    Stem Cells; 2005 Sep; 23(8):1192-9. PubMed ID: 15955830
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pluripotent cells in embryogenesis and in teratoma formation.
    Gordeeva OF
    J Stem Cells; 2011; 6(1):51-63. PubMed ID: 22997845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Goat embryonic stem-like cell derivation and characterization.
    Behboodi E; Lam L; Gavin WG; Bondareva A; Dobrinski I
    Methods Mol Biol; 2013; 1074():51-67. PubMed ID: 23975805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phosphoinositide 3-kinases and regulation of embryonic stem cell fate.
    Welham MJ; Storm MP; Kingham E; Bone HK
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):225-8. PubMed ID: 17371244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation of pluripotent stem cells from eggs of aging mice.
    Huang J; Okuka M; Wang F; Zuo B; Liang P; Kalmbach K; Liu L; Keefe DL
    Aging Cell; 2010 Apr; 9(2):113-25. PubMed ID: 20003168
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro.
    Bendall SC; Stewart MH; Menendez P; George D; Vijayaragavan K; Werbowetski-Ogilvie T; Ramos-Mejia V; Rouleau A; Yang J; Bossé M; Lajoie G; Bhatia M
    Nature; 2007 Aug; 448(7157):1015-21. PubMed ID: 17625568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chromatin-related proteins in pluripotent mouse embryonic stem cells are downregulated after removal of leukemia inhibitory factor.
    Kurisaki A; Hamazaki TS; Okabayashi K; Iida T; Nishine T; Chonan R; Kido H; Tsunasawa S; Nishimura O; Asashima M; Sugino H
    Biochem Biophys Res Commun; 2005 Sep; 335(3):667-75. PubMed ID: 16099433
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1.
    Zhang J; Tam WL; Tong GQ; Wu Q; Chan HY; Soh BS; Lou Y; Yang J; Ma Y; Chai L; Ng HH; Lufkin T; Robson P; Lim B
    Nat Cell Biol; 2006 Oct; 8(10):1114-23. PubMed ID: 16980957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isolation and differentiation of medaka embryonic stem cells.
    Hong Y; Schartl M
    Methods Mol Biol; 2006; 329():3-16. PubMed ID: 16845980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Directed differentiation and characterization of genetically modified embryonic stem cells for therapy.
    Lau AA; Hemsley KM; Meedeniya A; Robinson AJ; Hopwood JJ
    Methods Mol Biol; 2006; 329():471-84. PubMed ID: 16846011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Murine embryonic stem cell derivation, in vitro pluripotency characterization, and in vivo teratoma formation.
    Chou YF; Yabuuchi A
    Curr Protoc Toxicol; 2011 Nov; Chapter 2():Unit2.22. PubMed ID: 22058054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of chemical mutagenesis in mouse embryonic stem cells.
    Becker S; de Angelis MH; Beckers J
    Methods Mol Biol; 2006; 329():397-407. PubMed ID: 16846006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Internal standards in differentiating embryonic stem cells in vitro.
    Murphy CL
    Methods Mol Biol; 2006; 329():101-12. PubMed ID: 16845987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Attenuation of teratoma formation by p27 overexpression in induced pluripotent stem cells.
    Matsu-ura T; Sasaki H; Okada M; Mikoshiba K; Ashraf M
    Stem Cell Res Ther; 2016 Feb; 7():30. PubMed ID: 26880084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.